Hillstream Biopharma Buy Hold or Sell Recommendation
| HILSDelisted Stock | USD 0.39 0.01 2.50% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Hillstream Biopharma is 'Not Rated'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Hillstream Biopharma given historical horizon and risk tolerance towards Hillstream Biopharma. When Macroaxis issues a 'buy' or 'sell' recommendation for Hillstream Biopharma, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. Note, we conduct extensive research on individual companies such as Hillstream and provide practical buy, sell, or hold advice based on investors' constraints. Hillstream Biopharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Hillstream |
Execute Hillstream Biopharma Buy or Sell Advice
The Hillstream recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Hillstream Biopharma. Macroaxis does not own or have any residual interests in Hillstream Biopharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Hillstream Biopharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Hillstream Biopharma Trading Alerts and Improvement Suggestions
| Hillstream Biopharma is not yet fully synchronised with the market data | |
| Hillstream Biopharma has some characteristics of a very speculative penny stock | |
| Hillstream Biopharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (8.47 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Hillstream Biopharma currently holds about 9.48 M in cash with (6.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.82, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 39.0% of the company shares are held by company insiders |
Hillstream Biopharma current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Hillstream analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Hillstream analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Hillstream Biopharma Returns Distribution Density
The distribution of Hillstream Biopharma's historical returns is an attempt to chart the uncertainty of Hillstream Biopharma's future price movements. The chart of the probability distribution of Hillstream Biopharma daily returns describes the distribution of returns around its average expected value. We use Hillstream Biopharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Hillstream Biopharma returns is essential to provide solid investment advice for Hillstream Biopharma.
| Mean Return | -0.57 | Value At Risk | -7.89 | Potential Upside | 8.33 | Standard Deviation | 11.05 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Hillstream Biopharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Note: Acquisition by Milby Randy of 515127 shares of Hillstream Biopharma subject to Rule 16b-3 [view details]
Hillstream Biopharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Hillstream . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Hillstream Biopharma Buy or Sell Advice
When is the right time to buy or sell Hillstream Biopharma? Buying financial instruments such as Hillstream Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Hillstream Biopharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Small Blend Funds Thematic Idea Now
Small Blend Funds
Fund or Etfs that invest in stocks of small to mid-sized entities that have characteristics of both growth and value companies. The Small Blend Funds theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Small Blend Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Hillstream Stock
If you are still planning to invest in Hillstream Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hillstream Biopharma's history and understand the potential risks before investing.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |